Logo image of IREN

IREN LTD (IREN) Stock Fundamental Analysis

NASDAQ:IREN - Nasdaq - AU0000185993 - Common Stock - Currency: USD

9.75  +0.8 (+8.94%)

After market: 9.7699 +0.02 (+0.2%)

Fundamental Rating

3

Taking everything into account, IREN scores 3 out of 10 in our fundamental rating. IREN was compared to 283 industry peers in the Software industry. IREN may be in some trouble as it scores bad on both profitability and health. IREN is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year IREN has reported negative net income.
IREN had a negative operating cash flow in the past year.
In the past 5 years IREN always reported negative net income.
IREN had a positive operating cash flow in 4 of the past 5 years.
IREN Yearly Net Income VS EBIT VS OCF VS FCFIREN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

The Return On Assets of IREN (-1.79%) is better than 60.07% of its industry peers.
IREN has a better Return On Equity (-2.50%) than 62.90% of its industry peers.
Industry RankSector Rank
ROA -1.79%
ROE -2.5%
ROIC N/A
ROA(3y)-42.61%
ROA(5y)-38.24%
ROE(3y)-51.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IREN Yearly ROA, ROE, ROICIREN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IREN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IREN Yearly Profit, Operating, Gross MarginsIREN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

IREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
IREN has more shares outstanding than it did 1 year ago.
IREN has a better debt/assets ratio than last year.
IREN Yearly Shares OutstandingIREN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
IREN Yearly Total Debt VS Total AssetsIREN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

IREN has an Altman-Z score of 1.69. This is a bad value and indicates that IREN is not financially healthy and even has some risk of bankruptcy.
IREN has a Altman-Z score of 1.69. This is comparable to the rest of the industry: IREN outperforms 46.29% of its industry peers.
IREN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
IREN has a Debt to Equity ratio of 0.00. This is in the better half of the industry: IREN outperforms 69.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.69
ROIC/WACCN/A
WACC11.07%
IREN Yearly LT Debt VS Equity VS FCFIREN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

IREN has a Current Ratio of 0.46. This is a bad value and indicates that IREN is not financially healthy enough and could expect problems in meeting its short term obligations.
IREN's Current ratio of 0.46 is on the low side compared to the rest of the industry. IREN is outperformed by 91.52% of its industry peers.
IREN has a Quick Ratio of 0.46. This is a bad value and indicates that IREN is not financially healthy enough and could expect problems in meeting its short term obligations.
IREN has a worse Quick ratio (0.46) than 91.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
IREN Yearly Current Assets VS Current LiabilitesIREN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

IREN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.75%, which is quite impressive.
Looking at the last year, IREN shows a very strong growth in Revenue. The Revenue has grown by 149.98%.
IREN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 188.02% yearly.
EPS 1Y (TTM)90.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)149.98%
Revenue growth 3Y188.02%
Revenue growth 5YN/A
Sales Q2Q%172.49%

3.2 Future

The Earnings Per Share is expected to grow by 197.32% on average over the next years. This is a very strong growth
IREN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 70.38% yearly.
EPS Next Y445.97%
EPS Next 2Y471.88%
EPS Next 3Y197.32%
EPS Next 5YN/A
Revenue Next Year176.59%
Revenue Next 2Y123.24%
Revenue Next 3Y70.38%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IREN Yearly Revenue VS EstimatesIREN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
IREN Yearly EPS VS EstimatesIREN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

IREN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
IREN is valuated reasonably with a Price/Forward Earnings ratio of 9.83.
Based on the Price/Forward Earnings ratio, IREN is valued cheaper than 92.23% of the companies in the same industry.
IREN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.25, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 9.83
IREN Price Earnings VS Forward Price EarningsIREN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IREN Per share dataIREN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IREN's earnings are expected to grow with 197.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y471.88%
EPS Next 3Y197.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IREN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IREN LTD

NASDAQ:IREN (6/6/2025, 8:00:02 PM)

After market: 9.7699 +0.02 (+0.2%)

9.75

+0.8 (+8.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners45.49%
Inst Owner ChangeN/A
Ins Owners4.6%
Ins Owner ChangeN/A
Market Cap2.19B
Analysts83.33
Price Target21.5 (120.51%)
Short Float %14.34%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)171.1%
Min EPS beat(2)-22.73%
Max EPS beat(2)364.93%
EPS beat(4)1
Avg EPS beat(4)-232.62%
Min EPS beat(4)-1085.5%
Max EPS beat(4)364.93%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.74%
Min Revenue beat(2)-8.9%
Max Revenue beat(2)1.42%
Revenue beat(4)1
Avg Revenue beat(4)-4.4%
Min Revenue beat(4)-8.9%
Max Revenue beat(4)1.42%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.31%
PT rev (3m)-10.42%
EPS NQ rev (1m)-33.69%
EPS NQ rev (3m)-70.11%
EPS NY rev (1m)-37.53%
EPS NY rev (3m)-72.83%
Revenue NQ rev (1m)-5.33%
Revenue NQ rev (3m)-14.6%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-5.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.83
P/S 5.77
P/FCF N/A
P/OCF N/A
P/B 1.54
P/tB 1.54
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)0.99
Fwd EY10.17%
FCF(TTM)-2.56
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS1.69
BVpS6.35
TBVpS6.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.79%
ROE -2.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.61%
ROA(5y)-38.24%
ROE(3y)-51.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 110.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z 1.69
F-Score4
WACC11.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)123.51%
Cap/Sales(5y)130.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y445.97%
EPS Next 2Y471.88%
EPS Next 3Y197.32%
EPS Next 5YN/A
Revenue 1Y (TTM)149.98%
Revenue growth 3Y188.02%
Revenue growth 5YN/A
Sales Q2Q%172.49%
Revenue Next Year176.59%
Revenue Next 2Y123.24%
Revenue Next 3Y70.38%
Revenue Next 5YN/A
EBIT growth 1Y44.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5464.19%
EBIT Next 3Y384.47%
EBIT Next 5YN/A
FCF growth 1Y18.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y771.34%
OCF growth 3Y210.56%
OCF growth 5YN/A